Literature DB >> 11429066

Quality of life in laryngectomees: a post-treatment comparison of laryngectomy alone versus combined therapy.

V Paleri1, F W Stafford, T G Leontsinis, A J Hildreth.   

Abstract

Patients with advanced and recurrent laryngeal and hypopharyngeal cancer often need combined therapy, which is associated with greater morbidity than single modality treatment. The aim of this study was to assess the quality of life in laryngectomees and to assess whether differences exist between the irradiated and the non-irradiated patients. The University of Michigan Head and Neck Quality of Life questionnaire, a validated instrument for assessing the head and neck cancer related functional status and well-being, was used for this purpose. Subjects for the study included patients who had undergone total laryngectomy for laryngeal or hypophyarngeal squamous cancer. No significant difference between the groups was evident in the various domain scores, although a trend towards higher scores was seen in the combined therapy group. This study suggests that long-term side effects induced by radiotherapy do not adversely affect the quality of life in laryngectomised patients.

Entities:  

Mesh:

Year:  2001        PMID: 11429066     DOI: 10.1258/0022215011908144

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Quality-adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) 90-03: phase III randomized study comparing altered fractionation to standard fractionation radiotherapy for locally advanced head and neck squamous cell carcinoma.

Authors:  Andre A Konski; Kathryn Winter; Bernard F Cole; Kie-Kian Ang; Karen K Fu
Journal:  Head Neck       Date:  2009-02       Impact factor: 3.147

2.  Voice restoration following total laryngectomy by tracheoesophageal prosthesis: effect on patients' quality of life and voice handicap in Jordan.

Authors:  Abdelrahim Y Attieh; Jeff Searl; Nada H Shahaltough; Mahmoud M Wreikat; Donna S Lundy
Journal:  Health Qual Life Outcomes       Date:  2008-03-28       Impact factor: 3.186

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.